Dune Medical debuts waste-saving surgical probe

Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a  reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to

Medline buys Canadian stroke rehab device maker NeuroGym

Medline has acquired physical therapy and rehabilitation equipment maker NeuroGym Technologies of Ottawa, Ontario. NeuroGym’s equipment is designed for people who have had a stroke or other traumatic brain injury, spinal cord injury, chronic neurological conditions such as multiple sclerosis, balance issues and/or the need for fall prevention therapy. The equipment requires the patient to initiate

New Abingworth fund beats expectations

Lifesciences investment group Abingworth Bioventures has closed its latest fund, Abingworth Bioventures VII (ABV VII) at $315 million. The fund — Abingworth’s 12th invested in companies in Europe and the U.S. —  exceeded its target of $300 million.  The firm has more than $1.2 billion under management. The fund invests broadly across all stages of development, including early

Could this system make more kidneys, livers usable for transplant?

An Italian startup has teamed with critical-care immunotherapy company CytoSorbents Corporation (NASDAQ: CTSO) on an integrated ex-vivo system to perfuse, cleanse, recondition and preserve harvested kidneys and livers — including those that are usually discarded. Aferetica srl (Mirandola, Italy) designed its PerLife system is to improve organ function and viability while reducing the risk of primary graft failure

New robot takes on repetitive hair-restoration tasks

Restoration Robotics (Nasdaq: HAIR) has launched a robotic intelligent system that offers precise, minimally invasive, repeatable hair harvesting and implantation uses in one platform. The Artas iX robotic hair restoration system has a 3-camera stereoscopic vision system with 44-micron resolution and a 7-axis robot. It has a compact, motorized, battery-powered, portable and adjustable procedure chair for increased patient comfort and

Breast implant makers Polytech, G&G ink stock-swap merger pact

Silicone breast-implant makers Polytech Health & Aesthetics and G&G Biotechnology are getting together in a stock-swap merger. G&G designed the world’s first lightweight breast implant, the B-Lite, to reduce the impact of gravity on the reconstructed or augmented breast using technology developed by NASA to make its implants up to 30% lighter. The company sells its products in

Integer sells advanced surgical, ortho lines to MedPlast

Integer (NYSE:ITGR) has completed the spinoff of its advanced surgical and orthopedics products lines to MedPlast, LLC for $600 million in cash. Announced in May, the deal will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. MedPlast also announced that it will rebrand under the name

Clot-buster captures tiny particles, too

MIVI Neuroscience’s next-generation DAISe blood clot management system has had its first-in-human use for treatment of ischemic stroke. The procedure took place in South America, the company said in a statement. DAISe is designed to remove a clot as well as filter and capture clot emboli that fracture during removal.  It has a three-dimensional, vessel-conforming

How’d they do that? 7 innovations from medical device contract manufacturers

Charles Darwin wrote, “In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have prevailed.” Medical device companies get the credit for many innovations, but many need the ingenuity and commitment of contract manufacturers who design and produce the components that make those big splashes possible.

Pages: 1 2 3 4 5 6 7 8

CEL-SCI wins $2.9M in CRO legal battle

Score one for the little guy. After a four-year legal battle, immunotherapy maker CEL-SCI Corporation has won the first-ever breach-of-contract case against a contract research organization, or CRO. In a final and binding decision, an arbitrator concluded that CRO inVentiv knowingly and fraudulently misled CEL-SCI with regard to enrollment projections for a clinical trial of

Can placental tissue implants limit back and leg pain?

Regenerative technology company StimLabs has enrolled the first patient in a clinical trial using shelf-stable placental tissue to reduce complications following herniated disc surgery. The multi-center, randomized controlled trial will evaluate the safety and efficacy of Revita, StimLabs’ full-thickness placental allograft, which surgeons will place following lumbar microdiscectomy procedures. Microdiscectomy is a common, minimally invasive procedure

Stratasys spins off two companies

Stratasys is spinning off a pair of metal 3D printing companies, according to a report in IDTechEXResearch.  The first company, Evolve Additive, is working on a selective toner electrophotographic process (STEP), which uses an electrostatically charged roller that selectively collects polymeric particles in the position appropriate for the individual build layer. The roller then deposits particles

No-shows at radiology can cost a hospital $1 million a year, study says

People who fail to show up for radiology appointments cost hospitals about $1 million per year on average, according to a new study. That’s as much as the cost of a new 3T MR scanner. Most of the no-shows at academic medical centers were for mammography appointments, according to the study, published in Current Problems

Hey, Google! When will I die?

Google’s AI capabilities can predict with greater accuracy than a hospital’s computers when a critically ill patient will die, according to a new study. Using a patient’s entire chart, Google’s deep learning methods were able to predict, 24 hours after admission, the risk of that patient’s death at 19.9% while the regular hospital’s computers predicted

Bronchoscopes still dirty after cleaning, study says

A new study has found that currently acceptable methods of reprocessing reusable bronchoscopes left most devices contaminated and damaged. “The results are worrisome as patients undergoing bronchoscopy are commonly at high risk for infection due to transplant status, critical illness, or immune-suppression due to malignancy or chronic disease,” said the study, funded by 3M and